{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:01:54Z","timestamp":1780340514710,"version":"3.54.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Pharmaceuticals SpA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcmd.2026.102997","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:17:30Z","timestamp":1772849850000},"page":"102997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MRI-derived hepatic fat and its clinical correlates in non\u2013transfusion-dependent thalassemia: a cross-sectional study"],"prefix":"10.1016","volume":"119","author":[{"given":"Antonella","family":"Meloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pistoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ricchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Positano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Spasiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelia","family":"Borsellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Corigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Barbuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Zerbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Fina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Peritore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2026.102997_bb0005","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/bmj.314.7095.1675","article-title":"The thalassaemias","volume":"314","author":"Weatherall","year":"1997","journal-title":"Bmj"},{"key":"10.1016\/j.bcmd.2026.102997_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ijns5010016","article-title":"Thalassemias: an overview","volume":"5","author":"Angastiniotis","year":"2019","journal-title":"Int. J. Neonatal Screen"},{"key":"10.1016\/j.bcmd.2026.102997_bb0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2026.102997_bb0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0268-960X(12)70003-6","article-title":"The definition and epidemiology of non-transfusion-dependent thalassemia","volume":"26","author":"Weatherall","year":"2012","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2026.102997_bb0025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3324\/haematol.2012.066845","article-title":"Non-transfusion-dependent thalassemias","volume":"98","author":"Musallam","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2026.102997_bb0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2010.08220.x","article-title":"Age-related complications in treatment-naive patients with thalassaemia intermedia","volume":"150","author":"Taher","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0035","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102997_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4274\/Tjh.2014.0032","article-title":"beta-thalassemia intermedia: a bird\u2019s-eye view","volume":"31","author":"Haddad","year":"2014","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/bjh.16753","article-title":"Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study","volume":"191","author":"Ricchi","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejim.2011.05.013","article-title":"Risk factors for pulmonary hypertension in patients with beta thalassemia intermedia","volume":"22","author":"Karimi","year":"2011","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0055","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1002\/ajh.26056","article-title":"Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later","volume":"96","author":"Musallam","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010182","article-title":"Non-transfusion-dependent thalassemia: an update on complications and management","volume":"19","author":"Sleiman","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2026.102997_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/vox.12201","article-title":"When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia","volume":"108","author":"Taher","year":"2015","journal-title":"Vox Sang."},{"key":"10.1016\/j.bcmd.2026.102997_bb0070","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood-2011-03-283614","article-title":"Beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism","volume":"118","author":"Ginzburg","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102997_bb0075","doi-asserted-by":"crossref","DOI":"10.4081\/thal.2013.s1.e11","article-title":"Iron overload in non-transfusion-dependent thalassemia","volume":"3","author":"Musallam","year":"2013","journal-title":"Thal Rep."},{"key":"10.1016\/j.bcmd.2026.102997_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bjh.14373","article-title":"Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions","volume":"176","author":"Porter","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2026.102997_bb0085","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0268-960X(12)70006-1","article-title":"Iron overload in non-transfusion-dependent thalassemia: a clinical perspective","volume":"26","author":"Musallam","year":"2012","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2026.102997_bb0090","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.3324\/haematol.2013.097220","article-title":"Serum ferritin level and morbidity risk in transfusion-independent patients with beta-thalassemia intermedia: the ORIENT study","volume":"99","author":"Musallam","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2026.102997_bb0095","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3324\/haematol.13098","article-title":"Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia","volume":"93","author":"Taher","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2026.102997_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221084639","article-title":"Iron overload status in patients with non-transfusion-dependent thalassemia in China","volume":"13","author":"Huang","year":"2022","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0105","series-title":"Liver Pathophysiology","first-page":"279","article-title":"Chapter 21 - oxidative stress as a mechanism for hepatocellular carcinoma","author":"Tarocchi","year":"2017"},{"key":"10.1016\/j.bcmd.2026.102997_bb0110","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bcmd.2026.102997_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0037-1963(01)90060-5","article-title":"Progression of iron overload in sickle cell disease","volume":"38","author":"Olivieri","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.dld.2010.07.006","article-title":"Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases","volume":"43","author":"Fargion","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bcmd.2026.102997_bb0125","first-page":"501","article-title":"Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging","volume":"22","author":"Wahidiyat","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/JBM.S186362","article-title":"Thalassemia and hepatocellular carcinoma: links and risks","volume":"10","author":"Marsella","year":"2019","journal-title":"J. Blood Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood.V100.1.17","article-title":"Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation","volume":"100","author":"Angelucci","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102997_bb0140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","article-title":"Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China","volume":"165","author":"Man","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0145","article-title":"Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis","volume":"11","author":"Jin","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bcmd.2026.102997_bb0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0155","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bjh.15083","article-title":"The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients","volume":"180","author":"Ricchi","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/mrm.21522","article-title":"Joint estimation of water\/fat images and field inhomogeneity map","volume":"59","author":"Hernando","year":"2008","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0165","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/mrm.24593","article-title":"Multi-peak fat-corrected complex R2* relaxometry: theory, optimization, and clinical validation","volume":"70","author":"Hernando","year":"2013","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0170","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10334-018-0695-7","article-title":"Estimation of pancreatic R2* for iron overload assessment in the presence of fat: a comparison of different approaches","volume":"31","author":"Santarelli","year":"2018","journal-title":"Magma"},{"key":"10.1016\/j.bcmd.2026.102997_bb0175","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/bjh.19496","article-title":"Liver steatosis in patients with transfusion-dependent thalassaemia","volume":"204","author":"Ricchi","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jmri.22417","article-title":"Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload","volume":"33","author":"Meloni","year":"2011","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.bcmd.2026.102997_bb0185","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/mrm.22640","article-title":"Regional and global pancreatic T*(2) MRI for iron overload assessment in a large cohort of healthy subjects: Normal values and correlation with age and gender","volume":"65","author":"Restaino","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mrm.22410","article-title":"Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients","volume":"64","author":"Meloni","year":"2010","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0195","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/nbm.1121","article-title":"Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts","volume":"20","author":"Positano","year":"2007","journal-title":"NMR Biomed."},{"key":"10.1016\/j.bcmd.2026.102997_bb0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejmp.2020.06.019","article-title":"Determination of the R(2)* relaxation rate constant for estimating hepatic iron concentration: a customized approach that considers liver fat infiltration","volume":"76","author":"Gkotsis","year":"2020","journal-title":"Phys. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0205","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102997_bb0210","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bjh.12296","article-title":"The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages","volume":"161","author":"Meloni","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0215","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00261-015-0522-9","article-title":"Accurate estimate of pancreatic T2* values: how to deal with fat infiltration","volume":"40","author":"Meloni","year":"2015","journal-title":"Abdom. Imaging"},{"key":"10.1016\/j.bcmd.2026.102997_bb0220","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2026.102997_bb0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jmri.21781","article-title":"Multicenter validation of the magnetic resonance t2* technique for segmental and global quantification of myocardial iron","volume":"30","author":"Ramazzotti","year":"2009","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.bcmd.2026.102997_bb0230","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s00330-018-5783-6","article-title":"Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron","volume":"29","author":"Meloni","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0240","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2016.058","article-title":"The ICET-A recommendations for the diagnosis and management of disturbances of glucose homeostasis in thalassemia major patients","volume":"8","author":"De Sanctis","year":"2016","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.bcmd.2026.102997_bb0245","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajh.21626","article-title":"Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients","volume":"85","author":"Taher","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0250","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bjh.18492","article-title":"The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients","volume":"200","author":"Padeniya","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0255","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/jhep.2002.35064","article-title":"Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol","volume":"36","author":"Monto","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0260","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2004.01.011","article-title":"Hepatitis C virus and liver steatosis: when fat is not beautiful","volume":"40","author":"Negro","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0265","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","article-title":"Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen","volume":"20","author":"Lonardo","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0270","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.2003.018770","article-title":"Steatosis affects chronic hepatitis C progression in a genotype specific way","volume":"53","author":"Rubbia-Brandt","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bcmd.2026.102997_bb0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bcmd.2026.102997_bb0280","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/ijms17060803","article-title":"NAFLD and NASH in HCV infection: prevalence and significance in hepatic and extrahepatic manifestations","volume":"17","author":"Adinolfi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2026.102997_bb0285","first-page":"24","article-title":"Steatosis and hepatitis C","volume":"4","author":"Modaresi Esfeh","year":"2016","journal-title":"Gastroenterol. Rep. (Oxf)"},{"key":"10.1016\/j.bcmd.2026.102997_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360701713104","article-title":"Oxidative stress and iron homeostasis: mechanistic and health aspects","volume":"45","author":"Galaris","year":"2008","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.bcmd.2026.102997_bb0295","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bcmd.2026.102997_bb0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/molecules28010029","article-title":"Mitochondrial iron metabolism: the crucial actors in diseases","volume":"28","author":"Duan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcmd.2026.102997_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5124553","article-title":"Role of Iron-related oxidative stress and mitochondrial dysfunction in cardiovascular diseases","volume":"2022","author":"Yan","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bcmd.2026.102997_bb0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/JBM.S538996","article-title":"Iron overload and its impact on liver function and lipid profiles in transfusion-dependent \u03b2-thalassemia patients in Sana\u2019a City","volume":"16","author":"Al-Shami","year":"2025","journal-title":"J. Blood Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0315","first-page":"365","article-title":"Mitochondrial dysfunction, iron accumulation, lipid peroxidation, and inflammasome activation in cellular models derived from patients with multiple sclerosis","volume":"17","author":"Garc\u00eda-Salas","year":"2025","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcmd.2026.102997_bb0320","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00018-022-04423-x","article-title":"Iron increases lipid deposition via oxidative stress-mediated mitochondrial dysfunction and the HIF1\u03b1-PPAR\u03b3 pathway","volume":"79","author":"Song","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcmd.2026.102997_bb0325","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2026.102997_bb0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pbc.21275","article-title":"Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients","volume":"49","author":"Pakbaz","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2026.102997_bb0335","article-title":"Thalassemia intermedia: chelator or not?","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2026.102997_bb0340","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in non-alcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0345","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/hep.26238","article-title":"Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in non-alcoholic fatty liver disease","volume":"57","author":"Maliken","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0350","series-title":"Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis","article-title":"Regulation of Iron metabolism in NAFLD\/NASH","author":"Hamada","year":"2022"},{"key":"10.1016\/j.bcmd.2026.102997_bb0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","article-title":"Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0360","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.23219","article-title":"Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up","volume":"50","author":"Corey","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122778","article-title":"Iron overload and chelation therapy in non-transfusion dependent thalassemia","volume":"18","author":"Bou-Fakhredin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2026.102997_bb0370","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction","volume":"10","author":"Tanner","year":"2008","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bcmd.2026.102997_bb0375","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1182\/blood-2014-07-586677","article-title":"Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload","volume":"125","author":"Aydinok","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.102997_bb0380","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/bjh.15595","article-title":"MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine","volume":"183","author":"Pepe","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0385","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1532-429X-11-20","article-title":"The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study","volume":"11","author":"Berdoukas","year":"2009","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bcmd.2026.102997_bb0390","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bcmd.2011.07.002","article-title":"Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials","volume":"47","author":"Maggio","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2026.102997_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-15-1","article-title":"Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy","volume":"15","author":"Pepe","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bcmd.2026.102997_bb0400","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/en.2004-0392","article-title":"Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis","volume":"145","author":"Cooksey","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcmd.2026.102997_bb0405","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM198803313181303","article-title":"Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion","volume":"318","author":"Merkel","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0410","doi-asserted-by":"crossref","first-page":"287","DOI":"10.37349\/emed.2020.00019","article-title":"Non-alcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin","volume":"1","author":"Acierno","year":"2020","journal-title":"Explor. Med."},{"key":"10.1016\/j.bcmd.2026.102997_bb0415","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1586\/erc.11.15","article-title":"Hepatic steatosis and Type 2 diabetes: current and future treatment considerations","volume":"9","author":"Richard","year":"2011","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.bcmd.2026.102997_bb0420","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2010-2190","article-title":"Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes","volume":"96","author":"Sung","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2026.102997_bb0425","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Non-alcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcmd.2026.102997_bb0430","article-title":"Natural history of non-alcoholic fatty liver disease: implications for clinical practice and an individualized approach","volume":"2020","author":"Grgurevic","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcmd.2026.102997_bb0435","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dsi23-0015","article-title":"Non-alcoholic fatty liver disease in diabetes: a call to action","volume":"37","author":"Cusi","year":"2024","journal-title":"Diabetes Spectrum"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:07:51Z","timestamp":1780337271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979626000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":87,"alternative-id":["S1079979626000203"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.102997","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-derived hepatic fat and its clinical correlates in non\u2013transfusion-dependent thalassemia: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.102997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102997"}}